{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:50:58Z","timestamp":1791453058399,"version":"4.3.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005145","name":"Basic Research Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20251805"],"award-info":[{"award-number":["BK20251805"]}],"id":[{"id":"10.13039\/501100005145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"DOI":"10.1007\/s10585-026-10434-w","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:31:02Z","timestamp":1791174662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptional activation of EPHB1 by SOX2 promotes epithelial-mesenchymal transition and metastasis in esophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Jiaxi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"10434_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"10434_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","journal-title":"CA Cancer J Clin"},{"key":"10434_CR3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","volume":"13","author":"DJ Uhlenhopp","year":"2020","unstructured":"Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V (2020) Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 13:1010\u20131021. https:\/\/doi.org\/10.1007\/s12328-020-01237-x","journal-title":"Clin J Gastroenterol"},{"key":"10434_CR4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1200\/JCO.21.00601","volume":"40","author":"A Adenis","year":"2022","unstructured":"Adenis A, Kulkarni AS, Girotto GC, de la Fouchardiere C, Senellart H, van Laarhoven HWM, Mansoor W, Al-Rajabi R, Norquist J, Amonkar M et al (2022) Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181. J Clin Oncol 40:382\u2013391. https:\/\/doi.org\/10.1200\/JCO.21.00601","journal-title":"J Clin Oncol"},{"key":"10434_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/01.JAA.0001007328.84376.da","volume":"37","author":"DC Eisner","year":"2024","unstructured":"Eisner DC (2024) Esophageal cancer: Treatment advances and need for screening. JAAPA 37:19\u201324. https:\/\/doi.org\/10.1097\/01.JAA.0001007328.84376.da","journal-title":"JAAPA"},{"key":"10434_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009159","author":"EM Lisabeth","year":"2013","unstructured":"Lisabeth EM, Falivelli G, Pasquale EB (2013) Eph receptor signaling and ephrins. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a009159","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10434_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11033-025-11154-2","volume":"52","author":"P Prasun","year":"2025","unstructured":"Prasun P (2025) Eph-ephrin signaling and its potential role in female reproductive tract development. Mol Biol Rep 52:1037. https:\/\/doi.org\/10.1007\/s11033-025-11154-2","journal-title":"Mol Biol Rep"},{"key":"10434_CR8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41419-022-05385-5","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Peng Q, Xie Y, Yin N, Xu J, Chen A, Yi J, Shi W, Tang J, Xiang J (2022) Cell-cell contact-driven EphB1 cis- and trans- signalings regulate cancer stem cells enrichment after chemotherapy. Cell Death Dis 13:980. https:\/\/doi.org\/10.1038\/s41419-022-05385-5","journal-title":"Cell Death Dis"},{"key":"10434_CR9","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1038\/s41388-019-0931-2","volume":"38","author":"LY Liang","year":"2019","unstructured":"Liang LY, Patel O, Janes PW, Murphy JM, Lucet IS (2019) Eph receptor signalling: from catalytic to non-catalytic functions. Oncogene 38:6567\u20136584. https:\/\/doi.org\/10.1038\/s41388-019-0931-2","journal-title":"Oncogene"},{"key":"10434_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/s0092-8674(01)00314-2","volume":"105","author":"SM Shamah","year":"2001","unstructured":"Shamah SM, Lin MZ, Goldberg JL, Estrach S, Sahin M, Hu L, Bazalakova M, Neve RL, Corfas G, Debant A, Greenberg ME (2001) EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 105:233\u2013244. https:\/\/doi.org\/10.1016\/s0092-8674(01)00314-2","journal-title":"Cell"},{"key":"10434_CR11","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.18632\/oncotarget.3369","volume":"6","author":"S Bhatia","year":"2015","unstructured":"Bhatia S, Baig NA, Timofeeva O, Pasquale EB, Hirsch K, MacDonald TJ, Dritschilo A, Lee YC, Henkemeyer M, Rood B et al (2015) Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization. Oncotarget 6:8929\u20138946. https:\/\/doi.org\/10.18632\/oncotarget.3369","journal-title":"Oncotarget"},{"key":"10434_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12935-017-0384-z","volume":"17","author":"W Wei","year":"2017","unstructured":"Wei W, Wang H, Ji S (2017) Paradoxes of the EphB1 receptor in malignant brain tumors. Cancer Cell Int 17:21. https:\/\/doi.org\/10.1186\/s12935-017-0384-z","journal-title":"Cancer Cell Int"},{"key":"10434_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP (2016) Emt: 2016 Cell 166:21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Emt: 2016 Cell"},{"key":"10434_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/1759-7714.15196","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Pan B, Zhang F, Jia X, Zhu X, Tong X, Zhao J, Li C (2024) TPI1 promotes MAPK\/ERK-induced EMT, cell migration and invasion in lung adenocarcinoma. Thorac Cancer 15:327\u2013338. https:\/\/doi.org\/10.1111\/1759-7714.15196","journal-title":"Thorac Cancer"},{"key":"10434_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442\u2013454. https:\/\/doi.org\/10.1038\/nrc822","journal-title":"Nat Rev Cancer"},{"key":"10434_CR16","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1038\/s41388-020-1189-4","volume":"39","author":"X Tong","year":"2020","unstructured":"Tong X, Wang S, Lei Z, Li C, Zhang C, Su Z, Liu X, Zhao J, Zhang HT (2020) MYOCD and SMAD3\/SMAD4 form a positive feedback loop and drive TGF-beta-induced epithelial-mesenchymal transition in non-small cell lung cancer. Oncogene 39:2890\u20132904. https:\/\/doi.org\/10.1038\/s41388-020-1189-4","journal-title":"Oncogene"},{"key":"10434_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccr.2005.07.005","volume":"8","author":"M Macrae","year":"2005","unstructured":"Macrae M, Neve RM, Rodriguez-Viciana P, Haqq C, Yeh J, Chen C, Gray JW, McCormick F (2005) A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 8:111\u2013118. https:\/\/doi.org\/10.1016\/j.ccr.2005.07.005","journal-title":"Cancer Cell"},{"key":"10434_CR18","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00432-021-03618-2","volume":"147","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Cai C, Zhang M, Shi L, Wang J, Zhang H, Ma P, Li S (2021) Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT. J Cancer Res Clin Oncol 147:2013\u20132023. https:\/\/doi.org\/10.1007\/s00432-021-03618-2","journal-title":"J Cancer Res Clin Oncol"},{"key":"10434_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.stem.2012.12.007","volume":"12","author":"A Sarkar","year":"2013","unstructured":"Sarkar A, Hochedlinger K (2013) The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell 12:15\u201330. https:\/\/doi.org\/10.1016\/j.stem.2012.12.007","journal-title":"Cell Stem Cell"},{"key":"10434_CR20","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ng.465","volume":"41","author":"AJ Bass","year":"2009","unstructured":"Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I et al (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41:1238\u20131242. https:\/\/doi.org\/10.1038\/ng.465","journal-title":"Nat Genet"},{"key":"10434_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ccr.2014.06.024","volume":"26","author":"WL Tam","year":"2014","unstructured":"Tam WL, Ng HH (2014) Sox2: masterminding the root of cancer. Cancer Cell 26:3\u20135. https:\/\/doi.org\/10.1016\/j.ccr.2014.06.024","journal-title":"Cancer Cell"},{"key":"10434_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccr.2014.05.005","volume":"26","author":"RJ Vanner","year":"2014","unstructured":"Vanner RJ, Remke M, Gallo M, Selvadurai HJ, Coutinho F, Lee L, Kushida M, Head R, Morrissy S, Zhu X et al (2014) Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. Cancer Cell 26:33\u201347. https:\/\/doi.org\/10.1016\/j.ccr.2014.05.005","journal-title":"Cancer Cell"},{"key":"10434_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10585-022-10174-7","volume":"39","author":"T Xu","year":"2022","unstructured":"Xu T, Yan Z, Lu J, Chen L, Li X, Li Y, Dong Z, Guo W (2022) Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK1. Clin Exp Metastasis 39:757\u2013769. https:\/\/doi.org\/10.1007\/s10585-022-10174-7","journal-title":"Clin Exp Metastasis"},{"key":"10434_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrc2806","volume":"10","author":"EB Pasquale","year":"2010","unstructured":"Pasquale EB (2010) Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 10:165\u2013180. https:\/\/doi.org\/10.1038\/nrc2806","journal-title":"Nat Rev Cancer"},{"key":"10434_CR25","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s12032-011-0127-2","volume":"29","author":"F Hou","year":"2012","unstructured":"Hou F, Yuan W, Huang J, Qian L, Chen Z, Ge J, Wu S, Chen J, Wang J, Chen Z (2012) Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients. Med Oncol 29:2691\u20132700. https:\/\/doi.org\/10.1007\/s12032-011-0127-2","journal-title":"Med Oncol"},{"key":"10434_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s12253-008-9132-y","volume":"15","author":"W Yuan","year":"2009","unstructured":"Yuan W, Chen Z, Wu S, Ge J, Chang S, Wang X, Chen J, Chen Z (2009) Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis. Pathol Oncol Res 15:473\u2013478. https:\/\/doi.org\/10.1007\/s12253-008-9132-y","journal-title":"Pathol Oncol Res"},{"key":"10434_CR27","doi-asserted-by":"publisher","first-page":"4961883","DOI":"10.1155\/humu\/4961883","volume":"2025","author":"B Xu","year":"2025","unstructured":"Xu B, Lin S, Yang K (2025) EPHB1 Protein Promoted the Progression of Prostate Adenocarcinoma Through Phosphorylating GSK3B and Activating EPHB1-GSK3B-SMAD3 Pathway. Hum Mutat 2025:4961883. https:\/\/doi.org\/10.1155\/humu\/4961883","journal-title":"Hum Mutat"},{"key":"10434_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/cac2.12637","volume":"45","author":"LL Yao","year":"2025","unstructured":"Yao LL, Qin WT, Hu LP, Shi TZ, Yu Yang J, Li Q, Nie HZ, Li J, Wang X, Zhu L et al (2025) Reciprocal tumor-platelet interaction through the EPHB1-EFNB1 axis in the liver metastatic niche promotes metastatic tumor outgrowth in pancreatic ductal adenocarcinoma. Cancer Commun (Lond) 45:143\u2013166. https:\/\/doi.org\/10.1002\/cac2.12637","journal-title":"Cancer Commun (Lond)"},{"key":"10434_CR29","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/neuonc\/not128","volume":"15","author":"L Teng","year":"2013","unstructured":"Teng L, Nakada M, Furuyama N, Sabit H, Furuta T, Hayashi Y, Takino T, Dong Y, Sato H, Sai Y et al (2013) Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival. Neuro Oncol 15:1710\u20131720. https:\/\/doi.org\/10.1093\/neuonc\/not128","journal-title":"Neuro Oncol"},{"key":"10434_CR30","doi-asserted-by":"publisher","first-page":"105115","DOI":"10.1016\/j.jbc.2023.105115","volume":"299","author":"Y Kim","year":"2023","unstructured":"Kim Y, Ahmed S, Miller WT (2023) Colorectal cancer-associated mutations impair EphB1 kinase function. J Biol Chem 299:105115. https:\/\/doi.org\/10.1016\/j.jbc.2023.105115","journal-title":"J Biol Chem"},{"key":"10434_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00535-025-02219-x","volume":"60","author":"A Ota","year":"2025","unstructured":"Ota A, Shiozaki A, Shimizu H, Kosuga T, Kudou M, Nishibeppu K, Ohashi T, Arita T, Konishi H, Komatsu S et al (2025) Functions and clinical significance of KCNB1 in esophageal squamous cell carcinoma. J Gastroenterol 60:683\u2013695. https:\/\/doi.org\/10.1007\/s00535-025-02219-x","journal-title":"J Gastroenterol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-026-10434-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:04:17Z","timestamp":1791450257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-026-10434-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["10434"],"URL":"https:\/\/doi.org\/10.1007\/s10585-026-10434-w","relation":{},"ISSN":["1573-7276"],"issn-type":[{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee of First Affiliated Hospital of Soochow University(No.20251106). All the patients enrolled in this study provided written informed consent.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"51"}}